Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...
3d
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and mosunetuzumab, with ...
News-Medical.Net on MSN
Understanding age-related changes in T cells and vaccine response
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...
However, details of the intervening steps, as researchers have learned in the past 65 years, are quite complex — certain cells carry the flu antigen to the immune system, specific immune cells respond ...
MedPage Today on MSN
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...
Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armored) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback